Home » FDA Designates Renovia’s Leva Digital Therapeutic for Incontinence a Breakthrough
FDA Designates Renovia’s Leva Digital Therapeutic for Incontinence a Breakthrough
Renovia has received a Breakthrough Device designation from the FDA for its leva Digital Therapeutic System as a first-line treatment for chronic fecal incontinence in women.
The system is a small wand combined with a smartphone app that offers a drug-free way for women to train and strengthen their pelvic floor muscles. The treatment can be done at home and takes just five minutes a day, Renovia said.
The device already has 510(k) clearance to treat urinary incontinence in women, according to the Boston, Mass.-based company, which specializes in developing digital therapeutics for female pelvic floor disorders.
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May